Результати пошуку - Issam S. Hamadeh

  • Показ 1 - 8 результатів із 8
Уточнити результати
  1. 1
    Review of Opioid Pharmacogenetics and Considerations for Pain Management

    Review of Opioid Pharmacogenetics and Considerations for Pain Management за авторством Aniwaa Owusu Obeng, Issam S. Hamadeh, Michael A. Smith

    Опубліковано 2017
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  2. 2
    Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS)

    Osteonecrosis of the Jaw in the United States Food and Drug Administration's Adverse Event Reporting System (FAERS) за авторством Xiaoyan Zhang, Issam S. Hamadeh, Shuang Song, Joseph Katz, Jan S. Moreb, Taimour Langaee, Lawrence J. Lesko, Yan Gong

    Опубліковано 2015
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults

    Optimization of Voriconazole Therapy for the Treatment of Invasive Fungal Infections in Adults за авторством Naveen Mangal, Issam S. Hamadeh, Meghan J. Arwood, Larisa H. Cavallari, Tanay S. Samant, Kenneth Klinker, Jürgen B. Bulitta, Stephan Schmidt

    Опубліковано 2018
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  4. 4
    Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections

    Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections за авторством Issam S. Hamadeh, Kenneth Klinker, Samuel J. Borgert, Ashley Richards, Wenhui Li, Naveen Mangal, John W. Hiemenz, Stephan Schmidt, Taimour Langaee, Charles A. Peloquin, Julie A. Johnson, Larisa H. Cavallari

    Опубліковано 2017
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  5. 5
    Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate

    Impact of CYP2D6 Polymorphisms on Clinical Efficacy and Tolerability of Metoprolol Tartrate за авторством Issam S. Hamadeh, Taimour Langaee, R. Dwivedi, S. Gómez García, Ben Burkley, Todd C. Skaar, Arlene B. Chapman, John G. Gums, Stephen T. Turner, Yan Gong, Rhonda M. Cooper‐DeHoff, Julie A. Johnson

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma

    CD8 effector T cells enhance teclistamab response in BCMA-exposed and -naïve multiple myeloma за авторством Ross Firestone, Devin McAvoy, Tala Shekarkhand, Edith Serrano, Issam S. Hamadeh, Alice Wang, Menglei Zhu, Wei Ge Qin, Dhwani Patel, Carlyn Tan, Malin Hultcrantz, Sham Mailankody, Hani Hassoun, Urvi A. Shah, Neha Korde, Kylee Maclachlan, Heather Landau, Michael Scordo, Gunjan L. Shah, Oscar Lahoud, Sergio Giralt, Kazunori Murata, Kinga Hosszu, David J. Chung, Alexander M. Lesokhin, Saad Z. Usmani

    Опубліковано 2023
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy

    Phase 2 study of the safety and efficacy of umbralisib in patients with CLL who are intolerant to BTK or PI3Kδ inhibitor therapy за авторством Anthony R. Mato, Nilanjan Ghosh, Stephen J. Schuster, Nicole Lamanna, John M. Pagel, Ian W. Flinn, Jacqueline C. Barrientos, R. Kanti, James A. Reeves, Bruce D. Cheson, Paul M. Barr, Suman Kambhampati, Frederick Lansigan, Jeffrey J. Pu, Alan P Skarbnik, Lindsey E. Roeker, Gustavo Fonseca, Andrea Sitlinger, Issam S. Hamadeh, Colleen Dorsey, Nicole LaRatta, Hanna Weissbrot, Eline T. Luning Prak, Patricia Tsao, Dana Paskalis, Peter Sportelli, Hari P. Miskin, Michael Weiss, Jakub Svoboda, Danielle M. Brander

    Опубліковано 2020
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention

    Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention за авторством Larisa H. Cavallari, Craig R. Lee, Amber L. Beitelshees, Rhonda M. Cooper‐DeHoff, Julio D. Duarte, Deepak Voora, Stephen E. Kimmel, Caitrin W. McDonough, Yan Gong, Chintan V. Dave, Victoria M. Pratt, Tameka D. Alestock, R. David Anderson, Jorge Alsip, Amer Ardati, Brigitta C. Brott, Lawrence M. Brown, Supatat Chumnumwat, Michael Clare‐Salzler, James C. Coons, Joshua C. Denny, Chrisly Dillon, Amanda R. Elsey, Issam S. Hamadeh, Shuko Harada, William B. Hillegass, Lindsay J. Hines, Richard B. Horenstein, Lucius A. Howell, Linda Jo Bone Jeng, Mark D. Kelemen, Yee Ming Lee, Oyunbileg Magvanjav, May E. Montasser, David R. Nelson, Edith A. Nutescu, Devon Nwaba, Ruth E. Pakyz, Kathleen Palmer, Josh F. Peterson, Toni I. Pollin, Alison H. Quinn, Shawn Robinson, Jamie Schub, Todd C. Skaar, D. Max Smith, Vindhya Sriramoju, Petr Starostik, Tomasz Styŝ, James M. Stevenson, Nicholas Varunok, Mark R. Vesely, Dyson T. Wake, Karen E. Weck, Kristin Weitzel, Russell A. Wilke, James H. Willig, Yuqi Zhao, Rolf P. Kreutz, George A. Stouffer, Philip E. Empey, Nita A. Limdi, Alan R. Shuldiner, Almut G. Winterstein, Julie A. Johnson

    Опубліковано 2017
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: